Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
- 09 January 2025 - 1 mins read
The purpose of this study is to determine the efficacy and safety of a single dose of 750 U of Dysport compared to placebo for the improvement in the daily incontinence episode frequency for each administration mode in subjects suffering from neurogenic detrusor overactivity following spinal cord injury or multiple sclerosis.
09 January 2025
1 mins read
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
09 January 2025
1 mins read
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
09 January 2025
1 mins read
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
09 January 2025
1 mins read
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
09 January 2025
1 mins read
Dysport® Adult Lower Limb Spasticity Follow-on Study
09 January 2025
1 mins read
Dysport® Pediatric Lower Limb Spasticity Study
09 January 2025
1 mins read
Dysport® Adult Lower Limb Spasticity Study
09 January 2025
1 mins read
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
09 January 2025
1 mins read
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
09 January 2025
1 mins read